Stock Research: AxoGen

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

AxoGen

NasdaqCM:AXGN US05463X1063
63
  • Value
    26
  • Growth
    97
  • Safety
    Safety
    14
  • Combined
    36
  • Sentiment
    80
  • 360° View
    360° View
    63
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Axogen, Inc. focuses on technologies for peripheral nerve regeneration and repair, offering repair solutions for surgeons and healthcare providers. It operates in the medical devices industry. Axogen operates in the United States. In the last fiscal year, the company had 451 employees, a market cap of $537 million, profits of $142 million, and revenue of $187 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 63 (better than 63% compared with alternatives), overall professional sentiment and financial characteristics for the stock AxoGen are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for AxoGen. The consolidated Growth Rank has a good rank of 97, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 97% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 80, which means that professional investors are more optimistic about the stock than for 80% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 14, which means that the share price of AxoGen is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 86% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 26, which means that the company has a financing structure that is riskier than those of 74% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
14 31 64 63
Growth
97 93 51 25
Safety
Safety
26 7 16 64
Sentiment
80 74 49 68
360° View
360° View
63 51 34 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
84 87 92 56
Opinions Change
50 75 50 50
Pro Holdings
n/a 47 26 74
Market Pulse
81 31 34 37
Sentiment
80 74 49 68
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
14 31 64 63
Growth
97 93 51 25
Safety Safety
26 7 16 64
Combined
36 40 31 48
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
25 13 26 26
Price vs. Earnings (P/E)
35 41 75 79
Price vs. Book (P/B)
17 25 59 66
Dividend Yield
1 1 1 1
Value
14 31 64 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
88 70 57 53
Profit Growth
94 98 86 39
Capital Growth
38 51 61 63
Stock Returns
87 97 21 11
Growth
97 93 51 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
58 46 40 52
Refinancing
25 30 61 77
Liquidity
37 37 14 20
Safety Safety
26 7 16 64

Similar Stocks

Discover high‑ranked alternatives to AxoGen and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.